Because NAFLD, type 2 diabetes and CKD share the same pathology of obesity and insulin resistance [33], it is therefore hypothesized that serum irisin level was negatively associated with risk of CKD. The gene discussed is FNDC5; the disease is metabolic dysfunction-associated steatotic liver disease.